Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026)

Lemaitre Vascular (LMAT) reported Total Non-Current Liabilities of $221.6 million for Q1 2026, up 6.76% year-over-year from $207.6 million in Q1 2025, and little changed quarter-over-quarter from $221.7 million in Q4 2025.

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has 17 years of Total Non-Current Liabilities data on file, last reported at $221.6 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $221.6 million, up 6.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.6 million (up 6.76% YoY), and the FY2025 annual result was $221.7 million, up 3.61% from the prior year.
  • Total Non-Current Liabilities was little changed at $221.6 million in Q1 2026 per LMAT's latest filing, from $221.7 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $221.7 million in Q4 2025 and troughed at $33.9 million in Q1 2022.
  • A 5-year average of $103.2 million and a median of $43.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities plunged 50.93% in 2022, then soared 395.54% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $42.1 million in 2022, then advanced by 10.72% to $46.6 million in 2023, then jumped by 359.03% to $214.0 million in 2024, then gained by 3.61% to $221.7 million in 2025, then dropped by 0.03% to $221.6 million in 2026.
  • Business Quant data shows LMAT's Total Non-Current Liabilities at $221.6 million in Q1 2026, $221.7 million in Q4 2025, and $218.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 1.91 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 24.24 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 17.13 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 941.16 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 1.03 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 8.65 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 3.98 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 2.10 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 12.54 Bn
10 Lemaitre Vascular 2.12 Bn 1.75 Bn 48.40 Mn 221.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 221.59 Mn
Dec 31, 2025 221.67 Mn
Sep 30, 2025 218.54 Mn
Jun 30, 2025 214.59 Mn
Mar 31, 2025 207.56 Mn
Dec 31, 2024 213.96 Mn
Sep 30, 2024 45.32 Mn
Jun 30, 2024 43.31 Mn
Mar 31, 2024 43.28 Mn
Dec 31, 2023 46.61 Mn
Sep 30, 2023 43.23 Mn
Jun 30, 2023 42.06 Mn
Mar 31, 2023 40.07 Mn
Dec 31, 2022 42.10 Mn
Sep 30, 2022 38.40 Mn
Jun 30, 2022 38.89 Mn
Mar 31, 2022 33.90 Mn
Dec 31, 2021 35.95 Mn
Sep 30, 2021 39.67 Mn
Jun 30, 2021 56.12 Mn